Publications

2021 A few highlights from last year…

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Comm. 2021 Apr 16;12(1):230  doi: 10.1038/s41467-021-22465-w.

γδ T Cells Support Antigen-Specific αβ T cell-Mediated Antitumor Responses during BCG Treatment for Bladder Cancer. Cancer Immunol Res 2021 Dec;9(12):1491-1503. doi: 10.1158/2326-6066.CIR-21-0285. Epub 2021 Oct 4

Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer.Iyyanki T, Zhang B, Wang Q, Hou Y, Jin Q, Xu J, Yang H, Liu T, Wang X, Song F, Luan Y, Yamashita H, Chien R, Lyu H, Zhang L, Wang L, Warrick J, Raman JD, Meeks JJ, DeGraff DJ, Yue F.Genome Biol. 2021 Apr 15;22(1):105. doi: 10.1186/s13059-021-02325-y.

MutSignatures: an R package for extraction and analysis of cancer mutational signatures. Fantini D, Vidimar V, Yu Y, Condello S, Meeks JJ.Sci Rep. 2020 Oct 26;10(1):18217. doi: 10.1038/s41598-020-75062-0.

Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Robertson AG, Groeneveld CS, Jordan B, Lin X, McLaughlin KA, Das A, Fall LA, Fantini D, Taxter TJ, Mogil LS, Lindskrog SV, Dyrskjøt L, McConkey DJ, Svatek RS, de Reyniès A, Castro MAA, Meeks JJ.Eur Urol. 2020 Oct;78(4):533-537. doi: 10.1016/j.eururo.2020.06.048. Epub 2020 Jul 17.

Surgeon Scorecards Improve Muscle Sampling on Transurethral Resection of Bladder Tumor and Recurrence Outcomes in Patients with Nonmuscle Invasive Bladder Cancer. Das A, Cohen JE, Ko OS, Jordan BJ, Glaser AP, Auffenberg GB, Meeks JJ.J Urol. 2021 Mar;205(3):693-700. doi: 10.1097/JU.0000000000001372. Epub 2020 Oct 6.

A compilation of all publications can be found on PubMed or Google Scholar.

---